Dr. Oratz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
160 East 34th Street
4th Floor
New York, NY 10016Phone+1 212-731-5760- Is this information wrong?
Summary
- Dr. Ruth Oratz is an oncologist in New York, NY and is affiliated with NYU Langone Hospitals. She received her medical degree from Albert Einstein College of Medicine and has been in practice 35 years. She also speaks multiple languages, including French. She specializes in breast cancer, cancer genetics/cancer risk assessment.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1988
- NYU Grossman School of MedicineResidency, Internal Medicine, 1982 - 1985
- Albert Einstein College of MedicineClass of 1982
Certifications & Licensure
- NY State Medical License 1983 - 2025
- CO State Medical License 2003 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2020
- America's Top Doctors for Cancer Castle Connolly, 2008-2020
- Top Doctors: New York Metro Area Castle Connolly, 2002, 2008-2020
- Join now to see all
Clinical Trials
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases Start of enrollment: 2011 Aug 19
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Exemestane and Cyclophosphamide for Metastatic Breast Cancer Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R Donahue, Kenneth Bernstein...> ;Journal of Neuro-Oncology. 2024 Apr 17
- Hypocrisy of moral imperatives in the Israel-Hamas war.Hedy S Wald, Nicole Z Spence, Daniella M Schwartz, Steven Roth, Ruth Oratz> ;Lancet. 2024 Apr 20
- When medical duty and advocacy are one-sided, both sides suffer.Naomi T Katz, Yvonne Steinert, Ron Wald, Rivka Carmi, Ruth Oratz> ;Lancet. 2024 Apr 20
- Join now to see all
Press Mentions
- Many Women Underestimate Breast Density as a Risk Factor for Breast Cancer, Study ShowsJanuary 23rd, 2023
- Blood Test That Screens for 50 Cancers, Found Promising in Preliminary StudySeptember 13th, 2022
- To Counter Loneliness, Find Ways to ConnectJune 25th, 2018
- Join now to see all
Grant Support
- Interleukin 2 + Histamine Versus Interleukin 2 In Advance Malignant MelanomaNational Center For Research Resources1999–2002
- Bryostatin 1 (NSC339555) &Cisplatin In Advanced MalignanciesNational Center For Research Resources1999–2002
- Core--Clinical Research ResourcesNational Cancer Institute1999–2000
- Core--Patient Research ResourcesNational Cancer Institute1994–1998
Professional Memberships
- Member
- Member
- Fellow
Other Languages
- French
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: